|
⚲
|
| Keyboard |
| Xontogeny LLC
✚
|
|
|---|---|
| CIK # | 0001844296 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001844296] | |
| 4 | [0001844296] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Landos Biopharma Inc LABP
Stock Option (Right to Buy) · derivative
|
2021-08-27 | Grant | 10,709 | $0.00 | |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-09 | Buy | 34,951 | $14.60 | 510,285 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-09 | Buy | 64,730 | $13.80 | 893,274 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 1,250,000 | $16.00 | 20,000,000 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 1,770,600 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 2,941,769 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 2,857,795 | ||
|
Landos Biopharma Inc LABP
Series B Preferred Stock · derivative
|
2021-02-08 | Conversion | 1,770,600 | ||
|
Landos Biopharma Inc LABP
Series A Preferred Stock · derivative
|
2021-02-08 | Conversion | 2,941,769 | ||
|
Landos Biopharma Inc LABP
Series B Preferred Stock · derivative
|
2021-02-08 | Conversion | 2,857,795 | ||
|
Landos Biopharma Inc LABP
Series B Preferred Stock · derivative
|
2021-02-08 | Conversion | 2,857,795 | ||
|
Landos Biopharma Inc LABP
Series A Preferred Stock · derivative
|
2021-02-08 | Conversion | 2,941,769 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 34,611 | $11.38 | 393,873 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 86,671 | $12.53 | 1,085,988 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Buy | 1,771 | $13.10 | 23,200 |
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 2,941,769 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-08 | Conversion | 2,857,795 | ||
|
Landos Biopharma Inc LABP
Common Stock
|
2021-02-05 | Buy | 27,453 | $11.14 | 305,826 |
|
Catabasis Pharmaceuticals Inc CATB
Series X Convertible Preferred Stock · derivative
|
2021-02-01 | Grant | 4,851 | $3,009.53 | 14,599,230 |
|
Catabasis Pharmaceuticals Inc CATB
Series X Convertible Preferred Stock · derivative
|
2021-02-01 | Grant | 1,617 | $3,009.53 | 4,866,410 |